1999年至2020年美国西班牙裔人口癌症死亡率趋势.
Isabella R Pompa1, Anushka Ghosh1, Shamik Bhat2
1Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
JAMA oncology
|June 29, 2023
概括
对于西班牙裔个人来说,癌症死亡率总体上下降,但男性和女性的肝癌死亡率增加,女性的胰腺和子宫癌死亡率增加. 需要有针对性的干预措施来解决这些特定的癌症趋势.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 癌症是美国西班牙裔人士的主要死亡原因,尽管癌症死亡率总体下降.
- 在西班牙裔人口中了解癌症特异性死亡率 (CSM) 的趋势对于制定有针对性的公共卫生战略至关重要.
研究的目的:
- 在西班牙裔个人中分析从1999年到2020年的纵向癌症死亡率趋势.
- 为了比较西班牙裔和其他种族/种族人口之间的年龄调整癌症死亡率.
主要方法:
- 一项使用CDC WONDER数据库进行的横截面研究,以提取从1999年至2020年年龄调整后的癌症死亡率.
- 分析包括人口统计特征,癌症类型和美国人口普查地区.
- 其他种族和族裔人口的癌症死亡率在2000年,2010年和2020年被提取用于比较.
主要成果:
- 在西班牙裔个人中,CSM的总体发病率每年下降1.3%,男性的下降幅度比女性更大.
- 然而,在西班牙裔男性和女性中,肝癌的死亡率增加,在西班牙裔女性中,胰腺癌和子宫癌的死亡率增加.
- 在美国西部,西班牙裔男性和女性的肝癌死亡率显著增加.
结论:
- 尽管总体下降,但特定的癌症类型在西班牙裔人口中显示死亡率上升.
- 在各个年龄组和美国地区之间存在CSM率的差异.
- 可持续的,有针对性的干预措施是必要的,以扭转西班牙裔社区不良的癌症死亡率趋势.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
306
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.3K
相关概念视频
01:21Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
02:20Longitudinal Research
12.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.0K
01:20Comparing the Survival Analysis of Two or More Groups
228
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
228
02:59Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
01:08Prevalence and Incidence
641
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
641
01:24Kaplan-Meier Approach
195
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
195